Market revenue in 2023 | USD 217.2 million |
Market revenue in 2030 | USD 315.0 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Soil-transmitted helminthiases |
Fastest growing segment | Dracunculiasis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne Trematode Infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African Trypanosomiasis (sleeping sickness), Soil-transmitted Helminthiases, Onchocerciasis, Schistosomiasis, Scabies and Other Ecoparasites, Snakebite Envenoming, Leishmaniases |
Key market players worldwide | Roche, Abbott Laboratories, Thermo Fisher Scientific Inc, Eurobio-Scientific, Omega Laboratories, Avacta Group PLC, Oscar Health Inc Class A, ZeptoMetrix, InBios, DiaSys Diagnostic Systems |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neglected tropical diseases diagnosis market will help companies and investors design strategic landscapes.
Soil-transmitted helminthiases was the largest segment with a revenue share of 9.71% in 2023. Horizon Databook has segmented the Nigeria neglected tropical diseases diagnosis market based on dengue, chikungunya, rabies, leprosy, buruli ulcer, yaws, lymphatic filariasis, taeniasis/cysticercosis, foodborne trematode infections, echinococcosis, chagas disease, dracunculiasis, human african trypanosomiasis (sleeping sickness), soil-transmitted helminthiases, onchocerciasis, schistosomiasis, scabies and other ecoparasites, snakebite envenoming, leishmaniases covering the revenue growth of each sub-segment from 2018 to 2030.
According to WHO, Nigeria observes prevalence of many NTDs, including Buruli ulcer, trachoma, human African trypanosomiasis, lymphatic filariasis, dengue fever, onchocerciasis, schistosomiasis, and soil-transmitted helminths.
Poverty is another impact-rendering factor driving market growth in Nigeria. According to UNICEF, Nigeria is the 7th most populous nation in the world, and 70% of the population lives with less than USD 1 per day. Approximately 25% of NTDs burden in Africa is contributed by Nigeria.
Owing to high poverty in around 51% of the population, about 10 million individuals in Nigeria are at increased risk of NTDs or already have untreated cases of NTDs.
Horizon Databook provides a detailed overview of country-level data and insights on the Nigeria neglected tropical diseases diagnosis market , including forecasts for subscribers. This country databook contains high-level insights into Nigeria neglected tropical diseases diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account